ERAMET Project Open Day Activities: Get involved!
We are pleased to announce our upcoming Open Day, which will take place on April 15 during the upcoming Face-to-Face meeting. The event will bring together stakeholders, partners, and members…
New ERAMET Publication: Advancing the frontier of rare disease modeling: a critical appraisal of in silico technologies
“Advancing the frontier of rare disease modeling: a critical appraisal of in silico technologies” is ERAMET's newest publication appearing in Nature Digital Medicine. This new article published on 17th November,…
XVII Foresight training Course | From research to access: how does Europe speed up the availability of medicines for unmet needs? | 3-4 November | Online
ERAMET Project partner, Fondazione per la ricerca Farmacologica Gianni Benzi Onlus, will host the XVII edition of the Foresight Training Course, titled “From research to access: how does Europe speed…
ERAMET at PAGE 2025 in Thessaloniki: Advancing Model-Informed Drug Development in Paediatrics and Rare Diseases
ERAMET was proud to participate in PAGE 2025, held from June 3–6 at the Thessaloniki Concert Hall, where experts from across academia, regulatory agencies, and industry gathered to share and debate the latest in…
ERAMET Consortium Gathers at Face-to-Face Meeting at the University of Warwick
On March 31st and April 1st, the ERAMET project held its second Face-to-Face Consortium Meeting, bringing together representatives from all partner institutions involved in the initiative. Hosted at the University…
Kick-Off of the ERAMET Project: A New Era for Paediatric Medicines Development
The EU-funded ERAMET project is setting a new standard for the development of orphan and paediatric medicines. With an innovative approach that blends advanced modelling and simulation techniques with real-world…